Uterine Pgrmc2 Deficiency Attenuates Endometrial Hyperplasia and Cancer and Prolongs Lifespan in a Pten Loss-of-Function-Induced Cancer Model
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Deleting progesterone receptor membrane component 2 (PGRMC2) reduced endometrial hyperplasia and cancer in mice. This finding suggests PGRMC2 is a potential therapeutic target for endometrial cancer, especially when PTEN is deficient.
Area Of Science
- Gynecology
- Oncology
- Molecular Biology
Background
- Progesterone receptor membrane component (PGRMC) family members, especially PGRMC1, are upregulated in various cancers, particularly in the female reproductive system.
- Previous studies suggest PGRMC1 enhances tumor growth and chemoresistance, but the in vivo role of PGRMC family members in cancer development is not fully understood.
- PGRMCs function as cell survival factors crucial for normal uterine epithelial cell proliferation and female fertility.
Purpose Of The Study
- To investigate the role of PGRMC2 in the development of endometrial hyperplasia and cancer.
- To examine the effect of <i>Pgrmc2</i> deletion on a murine model of endometrial cancer with phosphatase and tensin homologue (<i>Pten</i>) loss-of-function.
Main Methods
- Utilized a murine conditional loss-of-function model for <i>Pten</i>.
- Assessed the impact of <i>Pgrmc2</i> deletion on the incidence and severity of endometrial hyperplasia and cancer.
- Evaluated the effect of <i>Pgrmc2</i> deletion on uterine glandular epithelial cell proliferation and uterine inflammation.
Main Results
- Deletion of <i>Pgrmc2</i> significantly reduced the incidence and severity of endometrial hyperplasia and cancer in mice with conditional <i>Pten</i>-heterozygous uteri.
- Mice with conditional <i>Pten</i>-knockout uteri lacking <i>Pgrmc2</i> exhibited increased lifespan.
- <i>Pgrmc2</i> deletion led to decreased uterine glandular epithelial cell proliferation, while uterine inflammation induced by <i>Pten</i> loss-of-function remained unaffected.
Conclusions
- PGRMC2 plays a significant role in promoting endometrial hyperplasia and cancer development, particularly in the context of reduced PTEN activity.
- Inhibition of PGRMC2 presents a potential therapeutic strategy for treating endometrial hyperplasia and cancer, especially in cases involving PTEN deficiency.
- This study identifies PGRMC2 as a promising therapeutic target for endometrial pathologies linked to PTEN dysfunction.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The uterus, commonly called the womb, is a vital reproductive organ in females designed to provide a nurturing environment for the implantation and growth of an embryo. It is shaped like a hollow pear and positioned between the urinary bladder and the rectum. The uterus's structure allows it to support and protect a developing fetus throughout pregnancy.
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs...
The uterine or fallopian tubes function as the conduit through which oocytes travel from the ovaries to the uterus. Each fallopian tube measures approximately 10 to 13 cm long and is anatomically divided into the infundibulum, ampulla, isthmus, and interstitial part (or intramural segment). The infundibulum is characterized by its funnel shape and features extensions called fimbriae which reach towards the peritoneal cavity. These fimbriae play a critical role during ovulation as they extend...
The uterine wall consists of three histological layers: the perimetrium, myometrium, and endometrium. The outermost perimetrium is a thin, serous membrane connected with the broad ligament on the sides, which helps anchor the uterus in the pelvic cavity. The thickest layer, myometrium, is mainly made up of smooth muscle tissue bundles. Its contractions are vital in facilitating the expulsion of the uterine lining, fetus, and placenta during menstruation and childbirth.
The endometrium is the...
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
The menstrual cycle is a recurrent sequence of changes in the uterine endometrium, specifically its functional layer, the stratum functionalis. This cycle prepares the uterus for potential pregnancy. This cycle typically spans 21–35 days, averaging 28 days, and aligns with the ovarian cycle, regulated by fluctuating levels of ovarian hormones, primarily estrogen and progesterone.
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a...